Good Samaritan Medical Center Brings New Technology and Services to the Newly Redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches

What To Know

  • “As we continue to change the way we treat breast cancer, it is important we continue to keep up with the latest and newest technology, so the residents of Palm Beach County can benefit from getting the very best treatments for their overall breast health,” said Sheri Montgomery, chief executive officer for Good Samaritan Medical Center.
  • The Palm Beach Health Network invested nearly a quarter of a million dollars into the center, bringing a sleek and calm aesthetic look, along with some of the newest high-end technology for patients being treated for their breast health.

Good Samaritan Medical Center part of the Palm Beach Health Network, has announced a new look and new equipment in the redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches.

The Palm Beach Health Network invested nearly a quarter of a million dollars into the center, bringing a sleek and calm aesthetic look, along with some of the newest high-end technology for patients being treated for their breast health.

“As we continue to change the way we treat breast cancer, it is important we continue to keep up with the latest and newest technology, so the residents of Palm Beach County can benefit from getting the very best treatments for their overall breast health,” said Sheri Montgomery, chief executive officer for Good Samaritan Medical Center. “As we have done for over 100 years, our newly redesigned center will continue to provide amazing quality care to the South Florida community.”

Some of the new additions to the center include:

  • The Genius 3D Mammography™ exam with Hologic Clarity HD – This technology generates images of the breast that are sharper and even more detailed so a cancer can be detected earlier, when it is easier to treat. It also cuts down on unnecessary follow-up appointments by up to 40% compared to 2D imaging alone. It also produces images quicker so less time for the patient to have their breast under compression
  • Affirm Breast Biopsy Guidance System – This system allows doctors to quickly perform 3D breast biopsies on patients and accurately target regions of interest for a breast biopsy assisting in breast cancer detection.
  • Supersonic Mach 40 Ultrasound – The Ultrasound system gives the highest resolution images of patients to enhance diagnostic certainty, regardless of tissue density.

“We feel confident that by offering these new technological capabilities it will ensure greater patient care and confidence for those who come in for their yearly mammograms,” said Dr. Elena Rehl, breast surgeon on staff at Good Samaritan Medical Center. “It is so important not to delay care, especially for your annual mammogram.  If you have been putting it off, we encourage you to make an appointment today.”

The Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches brings together a multi-disciplinary team of cancer specialists and allied health professionals, advanced technology and cancer resources so patients and their families may receive a comprehensive diagnosis, treatment and support services.  Call 561-650-6441 or visit www.goodsamaritanmc.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.
Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.
"The U.S. approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D., the Roger L. and Lynn C. Headrick Family Chair of the Valve Science Center for the Minneapolis Heart Institute Foundation and director of the Center for Valve and Structural Heart Disease for the Minneapolis Heart Institute at Abbott Northwestern Hospital and co-principal investigator of the TRILUMINATE™ Pivotal trial. "With TriClip, physicians can offer patients a therapy option backed by excellent safety and effectiveness to help restore tricuspid native valve performance without subjecting them to high-risk open-heart surgery that may not be feasible for individuals with TR who are generally older and sicker."
This make it one of the only wearable OTC anti-migraine device that is available without a prescription in the U.S.
NanoDrop has received clearance in the United States as the inaugural blood-lancing device available for over-the-counter use on the upper arm. This development is poised to revolutionize the consumer testing market and decentralized clinical trials within the realm of at-home healthcare.

By using this website you agree to accept Medical Device News Magazine Privacy Policy